Physician profile
Ebrahim Mamsa
NPI 1154572329
$1,201.41
in general payments reported to CMS, 2019-2025
8 companies · $73.92 in 2025
The $73.92 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $27.83 · 2021: $81.66 · 2022: $129 · 2023: $333 · 2024: $556 · 2025: $73.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846 · Education: $100 · Grant: $16.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.88 |
| Education | $100.00 |
| Grant | $16.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kulzer, LLC | $512.51 | 2023-2025 | |
| Straumann USA LLC | $279.37 | 2021-2023 | |
| Envista Holdings Corporation | $110.29 | 2024 | Spark |
| Kerr Corporation | $106.84 | 2023 | Files, Sonicfill, Herculite Ultra Flow |
| Nobel Biocare USA | $106.84 | 2023 | Nobelactive |
| Biohorizons Implant Systems INC. | $38.53 | 2020-2025 | Biohorizons Dental Implants |
| Dexcel Pharma Technologies LTD. | $32.74 | 2020-2021 | |
| Align Technology, INC. | $14.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ebrahim Mamsa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.